TGF-β and Megakaryocytes in the Pathogenesis of Myelofibrosis in Myeloproliferative Disorders

References

• Heuck G. Zwi Fälle von Leukämie mit eigenthümlichem blut-resp. Knochenmarksbefund. Virchows Archiv A 1879; 79: 475–496
   Google Scholar
• Buhr T., Georgii A., Choritz H. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover classification. Path. Res. Pract. 1993; 189: 121–132
   PubMed Web of Science ®Google Scholar
• Dameshek W. Some speculations on the myeloproliferative syndromes. Blood 1951; 6: 372–376
   PubMed Web of Science ®Google Scholar
• Ward H. P., Block M. H. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with myeloproliferative syndrome. Medicine (Baltimore) 1971; 50: 357–420
   PubMed Web of Science ®Google Scholar
• Rozman C., Giralt M., Feliu E., Rubio D., Cortes M. T. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991; 67: 2628–2663
   Web of Science ®Google Scholar
• Kahn A., Bernard J. F., Cottreau D., Marie J., Bovin P. A G-6-PD variant with heterozigous expression in blood cells of a woman with primary myelofibrosis. Humangenetik. 1975; 30: 41–46
   PubMedGoogle Scholar
• Jacobson R. J., Salo A., Fialkow P. J. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 1978; 51: 189–194
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H., Gray R. E., Thanwar S. L. Characteristics of bone marrow fibroblast colony forming cells and their progeny in patients with myeloproliferative disorders. Blood 1982; 59: 1046–1056
   PubMed Web of Science ®Google Scholar
• Buschle M., Janssen J. W. G., Drexler H., Lyons J., Anger B., Bartram C. R. Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterised by a N-ras gene mutation. Leukemia 1988; 2: 658–660
   PubMed Web of Science ®Google Scholar
• Wang J. C., Lang H. D., Lichter S., Weinstein M., Benn P. Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br. J. Haematol. 1992; 80: 184–188
   PubMed Web of Science ®Google Scholar
• Kreipe H., Jacquet K., Feigner J., Radzun H. J., Parwaresch M. R. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia. Blood 1991; 78: 1814–1817
   PubMed Web of Science ®Google Scholar
• Hibbin J. A., Njoku O. S., Matutes E., Lewis S. M., Goldman J. M. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br. J. Haematol. 1984; 57: 495–503
   PubMed Web of Science ®Google Scholar
• Dokal I., Jones L., Deenmamode M., Lewis S. M., Goldman J. M. Allogenic bone marrow transplantation for primary myelofibrosis. Br. J. Haematol. 1989; 71: 151–160
   Web of Science ®Google Scholar
• Burkhardt R., Frisch B., Bartl B. Bone marrow biopsy in haematological disorders. J. Clin. Pathol. 1982; 35: 257–284
   PubMed Web of Science ®Google Scholar
• Marcus R. E., Hibbin J. A., Matutes E., Whittle N., Waterfield M. D., Goldman J. M. Megakaryoblastic transformation of myelofibrosis with expression of the c-sis oncogene. Scand. J. Haematol. 1986; 36: 186–193
   PubMedGoogle Scholar
• Drouet L., Praloran V., Cywiner-Golenzer C., Trehen C., Flandrin G., Caen J. P. Déficit congénital en alpha granules plaquettaires et fibrose réticulinique médullaire. Hypothèse physiopathogénique. Nouv. Rev. Franç. Hématol. 1981; 23: 95–110
   PubMedGoogle Scholar
• Castro-Malaspina H., Rabellino E. M., Yen A., Nachman R. L., Moore M. A. S. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 1981; 57: 781–787
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. Myelofibrosis and the Biology of Connective Tissues. 1984; 427–454
   Google Scholar
• Baker R. I., Manorharan A. Platelet function in myeloproliferative disorders: characterisation and sequential studies show multiple platelet abnormalities, and change with time. Eur. J. Haematol. 1988; 40: 267–272
   PubMed Web of Science ®Google Scholar
• MartyrÉ M. C. Platelet PDGF and TGF-β levels in myeloproliferative disorders. Leukemia and Lymphoma 1991; 6: 1–6
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Hyodo H., Kuramoto A. Transforming growth factor-β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br. J. Haematol. 1989; 72: 486–491
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Kuramoto A. Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblasts. Br. J. Haematol. 1988; 68: 9–12
   Web of Science ®Google Scholar
• Derynck R., Jarett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian K., Roberts A. B., Sporn M. B., Goeddel D. V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–705
   PubMed Web of Science ®Google Scholar
• Barnard J. A., Lyons R. M., Moses H. L. The cell biology of transforming growth factor beta. Biochim. Biophys. Acta 1990; 1032: 79–87
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Spom M. B. The transforming growth factor-betas. Peptide Growth Factors and their Receptors, M. B. Sporn, A. B. Roberts. Springer, New York 1990
   Google Scholar
• Miyazono K., Hellman U., Wernstedt C., Heldin C. H. Latent high molecular weight complex of transforming growth factor-β1. J. Biol. Chem. 1988; 263: 6407–6415
   PubMed Web of Science ®Google Scholar
• Fava R. A., Casey T. T., Wilcox J., Pelton R. W., Moses H. L., Nanney L. B. Synthesis of transforming growth factor-β1 by megakaryocytes and its localisation to megakaryocytes and α-granules. Blood 1990; 76: 1946–1955
   PubMed Web of Science ®Google Scholar
• Hasselbach H. C. Idiopathic myelofibrosis. Danish Med. Bull. 1993; 40: 39–47
   PubMed Web of Science ®Google Scholar
• Apaja-Sarkkinen M., Autio-Harmainen Alavaikko M., Risteli J., Risteli L. Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. Br. J. Haematol. 1986; 63: 571–580
   PubMed Web of Science ®Google Scholar
• Reilly J. T., Nash J. G. R., Mackie M. J., McVerry B. A. Immunoenzymatic detection of fibronectin in normal and pathological haematopoietic tissue. Br. J. Haematol. 1985; 59: 497–504
   PubMed Web of Science ®Google Scholar
• Soini Y., Kamel D., Apaja-Sarkkinen M., Virtanen L., Lehto V. P. Tenascin immunoreactivity in normal and pathological bone marrow. J. Clin. Pathol. 1993; 46: 218–221
   PubMed Web of Science ®Google Scholar
• Reilly J. T., Nash J. G. R. Vitronectin (serum spreading factor) its localisation in normal and fibrotic tissue. J. Clin. Pathol. 1988; 59: 1269–1272
   Web of Science ®Google Scholar
• Ignotz R., Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 1986; 261: 4337–4345
   PubMed Web of Science ®Google Scholar
• Pearson C. A., Pearson D., Shibahara S., Hofsteenge J., Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-β. EMBO J. 1988; 7: 2977–2981
   PubMed Web of Science ®Google Scholar
• Edwards D. R., Murphy G., Reynolds J. J., Whitham S. E., Docherty A. J. P., Angel P., Heath J. K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987; 6: 1899–1904
   PubMed Web of Science ®Google Scholar
• Laiho M., Saksela O., Keski-Oja J. Transforming growth factor β induction of type-I plasminogen activator inhibitor. J. Biol. Chem. 1987; 262: 17467–17474
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield I. M., Heine U. I., Liotta L. A., Falanga V., Kehrl J. H., Fauci A. S. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation. in vitro. Proc. Natl. Acad. Sci. USA 1986; 83, 4167–4171
   Web of Science ®Google Scholar
• Thiele J., Rompcik V., Wagner S., Fischer R. Vascular architecture of collagen type IV in primary myelofibrosis and poly-cythaemia vera: an immunomorphometric study of trephine biopsies of the bone marrow. Br. J. Haematol. 1992; 80: 227–234
   PubMed Web of Science ®Google Scholar
• Raghow R. Role of transforming growth factor-β in repair and fibrosis. Chest 1991; 99: 618
   Web of Science ®Google Scholar
• Connor T. B., Roberts A. B., Sporn M. B., Danielpour D., Dart L. L., Michels R. G., De Bustros S., Enger C., Kato C., Lansing M., Hayashi H., Glaser B. M. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J. Clin. Invest. 1989; 83: 1661–1666
   PubMed Web of Science ®Google Scholar
• Castilla A., Pricto J., Fausto N. Transforming growth factors β1 and α in chronic liver disease: effects of interferon alfa therapy. New Engl. J. Med. 1991; 324: 933–940
   PubMed Web of Science ®Google Scholar
• Broekelmann T. J., Limper A. H., Colby T. V., Macdonald J. A. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 1991; 88: 6642–6646
   PubMed Web of Science ®Google Scholar
• Kulosik M. A., Hogg B., Lankat-Bittgereit H., Krieg T. Colocalization of transforming growth factor-β2 with α1 (I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J. Clin. Invest. 1990; 86: 917–922
   PubMed Web of Science ®Google Scholar
• Terui T., Niitsu Y., Mahara K., Fujisaki Y., Urushizaki Y., Mogi Y., Kohgo Y., Watanabe N., Ogura M., Saito H. The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implication in myelofibrosis. Blood 1990; 75: 1540–1548
   PubMed Web of Science ®Google Scholar
• Reilly J. T., Bamett D., Dolan G., Forrest P., Eastham J., Smith A. Characterisation of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis. Br. J. Haematol. 1993; 83: 58–62
   PubMed Web of Science ®Google Scholar
• Kitagawa M., Yoshida S., Ishige I., Minami J., Kuwata T., Tanizawa T., Kamiyama R. Immunolocalization of platelet-derived growth factor, transforming growth factor-β, and fibronectin in acute megakaryoblastic leukemia manifesting tumor formation. Hum. Pathol. 1994; 25: 723–726
   PubMed Web of Science ®Google Scholar
• MartyrÉ M. C., Magdelenat H., Bryckaert H., LainÉ-Bidron C., Calvo F. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br. J. Haematol. 1991; 77: 80–86
   PubMed Web of Science ®Google Scholar
• Zauli G., Visani C., Catani L., Vianelli N., Gugliotta L., Capitani S. Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor-β1 produced in normal amounts in patients with essential thrombocythaemia. Br. J. Haematol. 1993; 83: 14–20
   PubMed Web of Science ®Google Scholar
• MartyrÉ M. C., Magdelenat H., Calvo F. Interferon gamma in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. Br. J. Haematol. 1991; 77: 431–435
   PubMed Web of Science ®Google Scholar
• MartyrÉ M. C., Romquin N., Le Bousse-Kerdiles M. C., Chevillard S., Benyahia B., Dupriez B., Demory J. L., Bauters F. Transforming growth factor-β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br. J. Haematol. 1994; 88: 9–16
   PubMed Web of Science ®Google Scholar
• McCartney-Francis N. L., Wahl S. M. Transforming growth factor β: a matter of life and death. J. Leuk. Biol. 1994; 55: 401–409
   PubMed Web of Science ®Google Scholar
• Lopez-Casillas F., Cheifetz S., Doody J., Andres J. L., Lane W. S., MassaguÉ J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell 1991; 67: 785–795
   PubMed Web of Science ®Google Scholar
• Wrana J. L., Attisano L., Wieser R., Ventura F., MassaguÉ J. Mechanism of activation of the TGF-β receptor. Nature, 370: 341–347
   PubMed Web of Science ®Google Scholar
• Brunner G., Nguyen H., Gabrilove J., Rifkin D. B., Wilson E. L. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993; 81: 631–638
   PubMed Web of Science ®Google Scholar
• Avraham H., Banu N., Scadden D. T., Abraham J., Groopman J. E. Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 1994; 83: 2126–2132
   PubMed Web of Science ®Google Scholar
• Lok S., Kaushansky K., Holly R. D., Kujiper J. L., Lofton-Day C. E., Oort P. J., Grant F. J., Heipel M. D., Burkhead S. K., Kramer J. M., Bell L. A., Sprecher C. A., Blumberg H., Johnson R., Prunkard D., Ching A. F. T., Mathewes S. L., Beiley M. C., Forstrom J. W., Buddle M. M., Osborn S. G., Evans S. J., Shezppard P. O., Presnell S. R., O'Hara P. J., Hagen F. S., Roth G. J., Foster D. C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production. in vivo. Nature 1994; 369, 565–568
   Web of Science ®Google Scholar
• Vigon I., Mornon J. P., Cocault L., Mitjavila M. T., Tambourin P., Gisselbrecht S., Souyri M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc. Natl. Acad. Sci. USA 1992; 89: 5640–5644
   PubMed Web of Science ®Google Scholar
• Kaushanski K., Lok S., Holly R. D., Broudy V. C., Lin N., Balley M. C., Forstrom J. W., Buddle M. M., Oort P. J., Hagen F. S., Roth G. J., Papayannopoulou T., Foster D. C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar